BRCA2 and breast carcinoma: In addition to OC, RRBSO is associated with a 40–70% reduced risk of breast cancer in the BRCA 1/2 mutation carrier population, with effects particularly in premenopausal BRCA2 carriers, but more recently in both BRCA 1/2 [57,58].